polyethylene glycol 3350 100000 MG / potassium chloride 1000 MG / sodium chloride 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution

RxCUI
2045233
RxNorm name
polyethylene glycol 3350 100000 MG / potassium chloride 1000 MG / sodium chloride 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution
Display name
Polyethylene glycol 3350/Potassium chloride/Sodium chloride/Sodium sulfate (Oral Solution Powder)
Full name
polyethylene glycol 3350 100000 MG / potassium chloride 1000 MG / sodium chloride 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution
Term type
SCD
Status
Active
Strength
100,000-1,000-2,000-9,000 mg
Dose form
Pwdr
Route
Oral Solution Powder
Updated
2026-11-06 11:40:27

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062018
Active start
062018
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
polyethylene glycol 3350100000 MG / 1 EACHpolyethylene glycol 3350polyethylene glycol 3350
sodium sulfate9000 MG / 1 EACHsodium sulfatesodium sulfate
potassium chloride1000 MG / 1 EACHpotassium chloridepotassium chloride
sodium chloride2000 MG / 1 EACHsodium chloridesodium chloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Powder for Oral Solution1540455

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
polyethylene glycol 3350221147
sodium sulfate36721
potassium chloride8591
sodium chloride9863

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PlenvuPOLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATESalix Pharmaceuticals, Inc79f930fa-5674-4f30-8ae8-9448d62437972023-09-01Warnings, Adverse reactionsExact identifier
rxcui: 2045233

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
79f930fa-5674-4f30-8ae8-9448d6243797polyethylene glycol 3350 100 GM / potassium chloride 1 GM / sodium chloride 2 GM / sodium sulfate 9 GM Powder for Oral Solution [PSN] · polyethylene glycol 3350 100000 MG / potassium chloride 1000 MG / sodium chloride 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution [SCD] · polyethylene glycol 3350 100 GM / potassium chloride 1 GM / sodium chloride 2 GM / sodium sulfate 9 GM Powder for Oral Solution [SY] · POLYETHYLENE GLYCOL 3350 100000 MG / K+ Chloride 1000 MG / NaCl 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution [SY] · POLYETHYLENE GLYCOL 3350 100000 MG / Pot Chloride 1000 MG / NaCl 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution [SY]512These highlights do not include all the information needed to use PLENVU safely and effectively. See full prescribing information for PLENVU. PLENVU ® (polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride for oral solution) Initial U.S. Approval: 200620230901

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCB05XAElectrolyte solutionsATC1-4potassium chloride
ATCB05XAElectrolyte solutionsATC1-4sodium chloride
ATCA06ADOsmotically acting laxativesATC1-4sodium sulfate
ATCA12BAPotassiumATC1-4potassium chloride
ATCB05CBSalt solutionsATC1-4sodium chloride
ATCA12CASodiumATC1-4sodium sulfate
ATCA12CASodiumATC1-4sodium chloride
FDASPLN0000175811Osmotic LaxativeEPChas_epcpolyethylene glycol 3350
FDASPLN0000010288Osmotic ActivityMOAhas_moapolyethylene glycol 3350
FDASPLN0000009871Stimulation Large Intestine Fluid/Electrolyte SecretionPEhas_pepolyethylene glycol 3350
MEDRTD011092Polyethylene GlycolsCHEMhas_ingredientpolyethylene glycol 3350
MEDRTD011189Potassium ChlorideCHEMhas_ingredientpotassium chloride
MEDRTD012965Sodium ChlorideCHEMhas_ingredientsodium chloride
MEDRTD013431SulfatesCHEMhas_ingredientsodium sulfate
MEDRTD000224Addison DiseaseDISEASEci_withpotassium chloride
MEDRTD000471AlkalosisDISEASEci_withsodium chloride
MEDRTD003248ConstipationDISEASEmay_treatpolyethylene glycol 3350
MEDRTD015715Corneal EdemaDISEASEmay_treatsodium chloride
MEDRTD003681DehydrationDISEASEmay_preventsodium chloride
MEDRTD003681DehydrationDISEASEmay_treatsodium chloride
MEDRTD003681DehydrationDISEASEci_withpotassium chloride
MEDRTD004342Drug HypersensitivityDISEASEci_withpolyethylene glycol 3350
MEDRTD004342Drug HypersensitivityDISEASEci_withpotassium chloride
MEDRTD004342Drug HypersensitivityDISEASEci_withsodium chloride
MEDRTD015352Dry Eye SyndromesDISEASEmay_treatsodium chloride
MEDRTD004487EdemaDISEASEci_withsodium chloride
MEDRTD018589GastroparesisDISEASEci_withpolyethylene glycol 3350
MEDRTD006947HyperkalemiaDISEASEci_withpotassium chloride
MEDRTD006955HypernatremiaDISEASEci_withsodium chloride
MEDRTD007008HypokalemiaDISEASEmay_treatpotassium chloride
MEDRTD007008HypokalemiaDISEASEmay_preventpotassium chloride
MEDRTD007010HyponatremiaDISEASEmay_treatsodium chloride
MEDRTD007415Intestinal ObstructionDISEASEci_withpotassium chloride
MEDRTD007415Intestinal ObstructionDISEASEci_withpolyethylene glycol 3350
MEDRTD007416Intestinal PerforationDISEASEci_withpolyethylene glycol 3350
MEDRTD008532Megacolon, ToxicDISEASEci_withpolyethylene glycol 3350
MEDRTD020513Paralysis, Hyperkalemic PeriodicDISEASEci_withpotassium chloride
MEDRTD011654Pulmonary EdemaDISEASEci_withsodium chloride
MEDRTD051437Renal InsufficiencyDISEASEci_withpotassium chloride
MEDRTD012771Shock, HemorrhagicDISEASEmay_treatsodium chloride
MEDRTD014947Wounds and InjuriesDISEASEmay_treatsodium chloride
MEDRTN0000000226Acid-Base ActivityMOAhas_moapotassium chloride
MEDRTN0000000226Acid-Base ActivityMOAhas_moasodium chloride
MEDRTN0000000220Electrolyte ActivityMOAhas_moapotassium chloride
MEDRTN0000000220Electrolyte ActivityMOAhas_moasodium chloride
MEDRTN0000010288Osmotic ActivityMOAhas_moapolyethylene glycol 3350
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moapolyethylene glycol 3350
MEDRTN0000008294Alveolar Surface Tension ReductionPEhas_pesodium chloride
MEDRTN0000008337Cellular Activity AlterationPEhas_pepotassium chloride
MEDRTN0000008867Decreased Respiratory Secretion ViscosityPEhas_pesodium chloride
MEDRTN0000009360Increased Insulin SecretionPEhas_pepotassium chloride
MEDRTN0000009361Increased Intravascular VolumePEhas_pesodium chloride
MEDRTN0000009726Inhibition Large Intestine Fluid/Electrolyte AbsorptionPEhas_pepolyethylene glycol 3350
MEDRTN0000009774Organized Electrical Activity AlterationPEhas_pepotassium chloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH100000 MG / 1000 MG / 2000 MG / 9000 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESNDANDA209381
NAMESPrescribable Synonympolyethylene glycol 3350 100 GM / potassium chloride 1 GM / sodium chloride 2 GM / sodium sulfate 9 GM Powder for Oral Solution
SOURCESSourceMetathesaurus FDA Structured Product Labels